MindMaze Therapeutics Holding SA(DE:V6M)
€0.150.00 (-2.01%)
DE:V6M
MindMaze Therapeutics Holding SA financials statements
€0.15
At close:0.00 (-2.01%)
MindMaze Therapeutics Holding SA (V6M) Ratios
1 Followers
MindMaze Therapeutics Holding SA Ratios
DE:V6M's free cash flow for Q2 2025 was CHF-3.77M. For the 2025 fiscal year, DE:V6M's free cash flow was decreased by CHF-12.00K and operating cash flow was CHF-3.76M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.95 | 2.65 | 2.11 | 2.79 | 7.00 |
| Quick Ratio | 3.74 | 2.57 | 2.09 | 2.77 | 7.00 |
| Cash Ratio | 3.03 | 2.11 | 1.80 | 2.27 | 6.45 |
| Solvency Ratio | -0.88 | -3.93 | -1.08 | -0.47 | -0.71 |
| Operating Cash Flow Ratio | -0.59 | -2.55 | -2.25 | -1.81 | -2.72 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -52.26 | -14.59 | -26.55 | 0.00 |
| Net Current Asset Value | CHF 3.13M | CHF -5.86M | CHF -20.80M | CHF -15.12M | CHF 35.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 |
| Debt-to-Equity Ratio | 0.06 | 0.06 | 0.03 | 0.02 | 0.01 |
| Debt-to-Capital Ratio | 0.06 | 0.05 | 0.03 | 0.02 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.45 | 1.46 | 1.30 | 1.39 | 1.16 |
| Debt Service Coverage Ratio | -209.99 | -141.98 | -25.29 | -19.76 | -45.32 |
| Interest Coverage Ratio | -273.70 | -335.84 | -186.46 | -131.38 | -114.19 |
| Debt to Market Cap | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.18 | 0.28 | 0.43 | 0.50 | 0.18 |
| Net Debt to EBITDA | 0.77 | 0.11 | 0.30 | 1.24 | 6.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 69.41% | 68.18% | -197.78% | -258.54% | 0.00% |
| EBIT Margin | -229.14% | -1845.75% | -869.63% | -1045.71% | 0.00% |
| EBITDA Margin | -198.72% | -1793.50% | -826.51% | -984.40% | 0.00% |
| Operating Profit Margin | -224.37% | -1837.03% | -601.00% | -1060.22% | 0.00% |
| Pretax Profit Margin | -229.96% | -1851.22% | -893.21% | -1069.71% | 0.00% |
| Net Profit Margin | -203.39% | -1627.40% | -835.22% | -1045.02% | 0.00% |
| Continuous Operations Profit Margin | -203.39% | -1627.40% | -835.22% | -1045.02% | 0.00% |
| Net Income Per EBT | 88.44% | 87.91% | 93.51% | 97.69% | 125.03% |
| EBT Per EBIT | 102.49% | 100.77% | 148.62% | 100.89% | 32.44% |
| Return on Assets (ROA) | -32.16% | -128.53% | -26.90% | -13.79% | -10.03% |
| Return on Equity (ROE) | -46.69% | -187.99% | -34.93% | -19.12% | -11.68% |
| Return on Capital Employed (ROCE) | -39.15% | -159.51% | -20.52% | -15.18% | -27.05% |
| Return on Invested Capital (ROIC) | -34.28% | -138.51% | -18.97% | -14.73% | -33.82% |
| Return on Tangible Assets | -77.12% | -446.76% | -269.23% | -68.50% | -16.57% |
| Earnings Yield | -32.43% | -419.80% | -40.04% | -15.53% | -1.21% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.15 | 2.13 | 2.70 | 1.21 | 0.00 |
| Payables Turnover | 1.58 | 1.87 | 11.14 | 7.00 | 0.00 |
| Inventory Turnover | 2.47 | 3.45 | 79.77 | 30.45 | 0.00 |
| Fixed Asset Turnover | 3.51 | 2.03 | 2.26 | 1.31 | 0.00 |
| Asset Turnover | 0.16 | 0.08 | 0.03 | 0.01 | 0.00 |
| Working Capital Turnover Ratio | 0.64 | 0.52 | 0.26 | 0.09 | 0.00 |
| Cash Conversion Cycle | 5.06 | 82.67 | 107.17 | 261.68 | 0.00 |
| Days of Sales Outstanding | 87.99 | 171.64 | 135.35 | 301.80 | 0.00 |
| Days of Inventory Outstanding | 147.70 | 105.89 | 4.58 | 11.99 | 0.00 |
| Days of Payables Outstanding | 230.62 | 194.86 | 32.75 | 52.11 | 0.00 |
| Operating Cycle | 235.69 | 277.53 | 139.93 | 313.79 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.23 | -1.50 | -2.28 | -3.98 | -3.02 |
| Free Cash Flow Per Share | -0.25 | -1.54 | -2.33 | -5.50 | -3.02 |
| Dividend Paid and CapEx Coverage Ratio | -16.95 | -39.49 | -46.27 | -2.61 | 0.00 |
| Capital Expenditure Coverage Ratio | -16.95 | -39.49 | -46.27 | -2.61 | 0.00 |
| Operating Cash Flow Coverage Ratio | -1.36 | -5.94 | -5.55 | -8.38 | -20.46 |
| Operating Cash Flow to Sales Ratio | -0.35 | -2.92 | -3.96 | -10.75 | 0.00 |
| Free Cash Flow Yield | -5.85% | -77.21% | -19.42% | -22.11% | -2.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.08 | -0.24 | -2.50 | -6.44 | -82.93 |
| Price-to-Sales (P/S) Ratio | 6.27 | 3.88 | 20.86 | 67.30 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.44 | 0.45 | 0.87 | 1.23 | 9.68 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.10 | -1.30 | -5.15 | -4.52 | -35.60 |
| Price-to-Operating Cash Flow Ratio | -18.10 | -1.33 | -5.26 | -6.26 | -35.60 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.00 | -0.10 | -0.03 | 9.81 |
| Enterprise Value Multiple | -2.38 | -0.11 | -2.23 | -5.60 | -99.62 |
| Enterprise Value | 39.86M | 11.80M | 111.95M | 182.99M | 606.89M |
| EV to EBITDA | -2.38 | -0.11 | -2.23 | -5.60 | -99.62 |
| EV to Sales | 4.74 | 1.96 | 18.41 | 55.10 | 0.00 |
| EV to Free Cash Flow | -12.91 | -0.65 | -4.55 | -3.70 | -33.28 |
| EV to Operating Cash Flow | -13.67 | -0.67 | -4.64 | -5.12 | -33.28 |
| Tangible Book Value Per Share | 0.45 | -0.19 | -2.32 | -2.16 | 6.01 |
| Shareholders’ Equity Per Share | 2.92 | 4.44 | 13.76 | 20.21 | 11.11 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.12 | 0.12 | 0.06 | 0.02 | -0.25 |
| Revenue Per Share | 0.67 | 0.51 | 0.58 | 0.37 | 0.00 |
| Net Income Per Share | -1.37 | -8.35 | -4.80 | -3.86 | -1.30 |
| Tax Burden | 0.88 | 0.88 | 0.94 | 0.98 | 1.25 |
| Interest Burden | 1.00 | 1.00 | 1.03 | 1.02 | 1.03 |
| Research & Development to Revenue | 0.16 | 0.22 | 2.04 | 5.73 | 0.00 |
| SG&A to Revenue | 1.10 | 2.86 | 1.27 | 1.70 | 0.00 |
| Stock-Based Compensation to Revenue | 0.03 | 0.13 | 0.36 | 0.34 | 0.00 |
| Income Quality | 0.17 | 0.18 | 0.47 | 1.03 | 2.33 |
Currency in CHF
